Previous Article | Next Article 
Infection and Immunity, November 1998, p. 5119-5124, Vol. 66, No. 11
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Differential Expression of Borrelia
burgdorferi Proteins during Growth In Vitro
Ramesh
Ramamoorthy, and
Mario T.
Philipp*
Department of Parasitology, Tulane Regional
Primate Research Center, Tulane University Medical Center,
Covington, Louisiana 70433
Received 22 September 1997/Returned for modification 4 November
1997/Accepted 31 August 1998
 |
ABSTRACT |
In an earlier paper we described the transcriptionally regulated
differential levels of expression of two lipoproteins of Borrelia
burgdorferi, P35 and P7.5, during growth of the spirochetes in
culture from logarithmic phase to stationary phase (K. J. Indest, R. Ramamoorthy, M. Solé, R. D. Gilmore, B. J. B. Johnson, and M. T. Philipp, Infect. Immun. 65:1165-1171, 1997).
Here we further assess this phenomenon by investigating whether the
expression of other antigens of B. burgdorferi, including
some well-characterized ones, are also regulated in a
growth-phase-dependent manner in vitro. These studies revealed 13 additional antigens, including OspC, BmpD, and GroEL, that were
upregulated 2- to 66-fold and a 28-kDa protein that was downregulated
2- to 10-fold, during the interval between the logarithmic- and
stationary-growth phases. Unlike with these in vitro-regulated
proteins, the levels of expression of OspA, OspB, P72, flagellin, and
BmpA remained unchanged throughout growth of the spirochetes in
culture. Furthermore, ospAB, bmpAB, groEL, and fla all exhibited similar mRNA
profiles, which is consistent with the constitutive expression of these
genes. By contrast, the mRNA and protein profiles of ospC
and bmpD indicated regulated expression of these genes.
While bmpD exhibited a spike in mRNA expression in early
stationary phase, ospC maintained a relatively higher level
of mRNA throughout culture. These findings demonstrate that there are
additional genes besides P7.5 and P35 whose
regulated expression can be investigated in vitro and which may thus
serve as models to facilitate the study of regulatory mechanisms in an
organism that cycles between an arthropod and a vertebrate host.
 |
INTRODUCTION |
Borrelia burgdorferi, the
spirochete that causes Lyme disease, is a remarkably adaptable
bacterium. During its life cycle, it is able to survive in the midguts
of vector ticks (of the Ixodes ricinus complex) both in the
presence and absence of host blood and in the ticks' saliva. In
addition, after withstanding the transit between a poikilothermal and a
homeothermal host (usually a rodent) (16), it will colonize
practically every organ of the latter. It stands to reason that
numerous changes must take place on the spirochetal surface in
anticipation of, or after transfer to, a new host or host environment.
Several such changes have been observed, yet their functional
significance remains unknown. For example, following a tick blood meal,
there is a switch in the major surface protein from OspA to OspC
(5, 6, 23). Another antigen, P21, appears to be selectively
expressed in the mammalian host and not in ticks (3, 26).
However, little else is known about other adaptive changes, especially the ones that do not involve antigens, primarily due to the difficulty in harvesting a sufficient number of spirochetes from their hosts for
direct examination.
In a recent publication, we showed that the expression of two
plasmid-borne genes that encode the lipoproteins P35 (7, 8)
and P7.5 (11) of B. burgdorferi is upregulated in
the post-logarithmic and stationary phases during growth of the
spirochetes in culture (9). We demonstrated further that the
upregulation of expression of these genes correlated with higher levels
of their mRNA during the later stages of in vitro growth. The
phenomenon of growth phase regulation of genes in B. burgdorferi is of biological relevance because the spirochetal
population experiences alternating periods of rapid growth and
quiescence during its transit through the ticks (4, 19). We
therefore decided to investigate more thoroughly this phenomenon with
the long-term objective of developing models for understanding the life
cycle of the spirochete within a tick. As a result of this study, we
have now identified additional candidate proteins that are
differentially expressed or upregulated in B. burgdorferi
during growth in vitro from logarithmic to stationary phase. We present
the results of our study in this paper.
 |
MATERIALS AND METHODS |
Bacterial strains.
The JD1 strain of B. burgdorferi originally isolated from an Ixodes dammini
(scapularis) nymph (18) was used for this study. The Escherichia coli strain used was XL1 Blue (Stratagene,
La Jolla, Calif.).
In vitro culture conditions.
B. burgdorferi JD1
(passage 5) was cultured in BSK-H medium (Sigma Chemical Company, St.
Louis, Mo.) as described previously (20) with the following
modifications. Briefly, 750 ml of fresh BSK-H medium was inoculated
with 1.5 ml of a frozen stock of the JD1 strain of B. burgdorferi to yield a starting cell density of 105
spirochetes/ml. The cell density was monitored daily by counting spirochetes under dark-field microscopy. Cells were harvested on days 3 (at a cell density of 4 × 106 spirochetes per ml), 4 (2 × 107 per ml), 6 (8 × 107 per
ml), and 8 (1 × 108 per ml), and whole-cell lysates
for protein analysis and RNA for Northern blot analysis were prepared.
Sample volumes were adjusted for the various cell densities (see
below). An aliquot of cells in the stationary phase (day 8) was
reinoculated into fresh BSK-H medium at an initial density of
105 spirochetes per ml as described above and allowed to
progress to stationary phase, at which point the cells were subcultured for one final growth cycle. Cells in the log phase of this last subculture, i.e., of passage 8, hereinafter designated
"logrev" for log revertant, were also processed for
protein and RNA analyses as mentioned above.
Antibodies.
Mouse monoclonal antibodies H5332 and H9724,
specific for the B. burgdorferi proteins OspA and flagellin,
respectively, were purchased from the University of Texas Health
Sciences Center (San Antonio). Additional mouse monoclonal antibodies
that are specific to B. burgdorferi OspB, BmpA (P39), GroEL,
and a 72-kDa protein were kindly provided by Barbara Johnson, Division
of Vector-Borne Infectious Diseases, Centers for Disease Control and
Prevention, Ft. Collins, Colo., and an anti-OspC monoclonal antibody
(L221F8) (28) was provided by Bettina Wilske, Max von
Pettenkofer Institut, Munich, Germany. Finally, the P35-specific
monoclonal antibody has been described previously (9). A
mouse monospecific polyclonal antibody directed against the BmpD
protein of B. burgdorferi, was generated as follows. The
mature BmpD polypeptide starting at Cys17 was expressed
with a leader peptide, Met-Arg-Gly-Ser-His6-Gly-Ser-Cys, in
which the cysteine residue represents the first residue of the mature
BmpD sequence. This His6 affinity-peptide-tagged BmpD protein was purified with a nickel-nitrilotriacetic acid-agarose affinity column as per the instructions of the manufacturer
(Stratagene). C57BL/10.j mice were intraperitoneally immunized with 15 µg of the fusion protein emulsified in complete Freund's adjuvant
(Sigma). Thereafter, the mice received one of two more injections of
the same antigen in Freund's incomplete adjuvant (Sigma) at 1- and 2-months intervals and were bled 2 weeks after the last immunization.
Preparation of protein samples, SDS-PAGE, and Western
blotting.
Cultures (100 ml for sample 1 [4 × 106/ml] [see Fig. 1A] and 50 ml for the rest of the
samples) were spun down at 5,000 × g at 4°C for 10 min in a tabletop centrifuge and washed with 1 ml of a wash buffer (20 mM HEPES [pH 7.6], 10 mM NaCl) (2). The washed spirochetes
were then resuspended in 100 µl of the wash buffer, and the optical
density at 600 nm (OD600) of a 1:100 dilution of this was
measured in a spectrophotometer. The remainder of the cells was
adjusted with wash buffer and 3× sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (SDS-PAGE) lysis buffer such that the final lysate
concentration was equivalent to an OD600 of 1, thus
normalizing each sample by cell mass.
The protein samples (10 µl/lane) were electrophoresed through a
12.5% polyacrylamide gel and electroblotted onto nitrocellulose paper
(Schleicher & Schuell, Keene, N.H.). The transferred proteins were
reacted with B. burgdorferi-infected rhesus monkey serum (K216, 6 weeks postinfection) (22) or with monoclonal and
polyclonal antibody reagents specific for several well-characterized
B. burgdorferi antigens by a procedure described previously
(1). For staining of proteins with silver, lysate samples
were diluted 10-fold in sample buffer to a concentration equivalent to
an OD600 of 0.1 and processed according to the protocol of
the manufacturer (Bio-Rad, Hercules, Calif.).
RNA isolation and Northern blotting.
RNA isolation and
Northern blotting of spirochetal samples taken at specific time points
along the growth curve were performed essentially as described
previously (21). Equal amounts (3 µg/lane) of the RNA
samples were electrophoresed through a 1.4% agarose gel in the
presence of 2.2 M formaldehyde. In addition to spectrophotometrically quantifying RNA, we stained one blot with methylene blue prior to
hybridization to confirm equal loadings of the RNA samples that were
obtained at the different time points.
The DNA probes used for hybridization either were restriction fragments
from cloned genes or were generated by PCR. PCR primers were designed
to amplify only the coding sequences of the relevant genes. The probes
were radiolabeled with [
-32P]dATP and the Klenow
fragment of DNA polymerase I (Prime-a-Gene kit from Promega Biotech,
Madison, Wis.). Reaction mixtures were primed with either random
hexamers or gene-specific primers complementary to the RNA sequence.
All Northern blots were washed as described previously (21)
between 50 and 60°C and exposed to X-ray film.
Quantification of bands on Western and Northern blots.
The
blots were digitized with a scanner (Hewlett-Packard Scanjet 4c), and
individual bands in the digitized images were quantified with Digital
Science 1D software, version 2.02 (Eastman Kodak Company, Rochester,
N.Y.).
 |
RESULTS |
In a recent paper we described the cell density-dependent
expression of B. burgdorferi lipoproteins P7.5 and P35,
during growth of the spirochetes in culture (9). In this
study we explored the possibility that other B. burgdorferi
proteins were similarly differentially expressed during growth in
vitro. Samples collected at time points along the growth curve that
corresponded to the logarithmic (days 3 and 4), postlogarithmic (day
6), and stationary (day 8) phases were processed for protein and RNA
analysis (Fig. 1A). In order to
distinguish between proteins that are truly differentially expressed
versus those whose expression may be irreversibly affected for unknown
reasons, we also analyzed spirochetes from the same batch after they
had undergone two additional cycles of growth. Accordingly, we have
designated this sample of spirochetes harvested at a cell density
similar to that of the parental day 4 logarithmic phase culture
"logrev" to indicate the cells' phenotypic reversion to their predecessors' logarithmic-phase phenotype.

View larger version (42K):
[in this window]
[in a new window]
|
FIG. 1.
(A) Growth curve of B. burgdorferi JD1
(passage 6) in vitro. The arrows indicate the cell densities at which
spirochetes were harvested and processed for Western and Northern
blotting analyses. Numbers above the arrows designate each sample. The
open arrow depicts the passage 8 logrev sampling point. (B)
Silver-stained gel showing the profiles of proteins expressed at
different times during culture. The filled arrowhead indicates OspC,
and the open arrowhead indicates P28. The lane numbers correspond to
the numbers in panel A and designate the time point at which each
sample was collected. (C) Western blot developed with serum from a
monkey with an acute infection of B. burgdorferi JD1
(22). Arrowheads indicate antigens whose levels of
expression steadily increased with the increasing age of the culture.
Lane numbers are as described for panel B.
|
|
Profile of protein expression in B. burgdorferi during
growth from log to stationary phase in vitro.
Initially, we
analyzed the protein samples from the different time points along the
growth curve by one-dimensional SDS-PAGE followed by silver staining.
This method identified two proteins, 23 and 28 kDa in size, that were
differentially expressed against a background of several bands that
remained fairly constant in intensity (Fig. 1B). The level of
expression of the 28-kDa protein was 2-fold higher in the experiment
shown in Fig. 1B (Table 1) and 10-fold
higher in a previous experiment (data not shown) early during the
logarithmic phase than its level of expression in the stationary phase.
In contrast, increasing amounts of the 23-kDa protein accumulated
within the cell during growth from logarithmic to stationary phase
(Table 1). The 23-kDa band corresponded to the lipoprotein OspC
(discussed later). The other proteins that are also known to be
differentially expressed, such as P35 and P7.5 (9) and the
antigens newly identified in this study by Western blotting (see
below), are not apparent in the silver-stained gel, perhaps due to
their poor overall levels of expression (P35) or, in the case of P7.5,
because they were run off the gel.
In addition to silver staining, the same set of protein samples was
also examined by Western blotting with serum from a rhesus monkey with
an acute infection with spirochetes from the JD1 strain of B. burgdorferi in a search for antigens that are expressed early in
infection and are differentially regulated in vitro. This serum
recognized at least 18 distinct bands in the Western blot of the
whole-cell lysate from strain JD1 (Fig. 1C). Ten of these bands, which
correspond to proteins of 15, 16.5, 22, 23, 28, 29, 31, 34, 35, and
43.5 kDa, were upregulated between 2- to 50-fold during growth from
logarithmic phase to stationary phase (Fig. 1C; Table 1). More
specifically, the levels of expression of all 10 proteins steadily
increased between days 3 (logarithmic phase) and 8 (stationary phase)
of culture, an expression pattern similar to those described for P35
and P7.5 (9). It is very likely that the 23- and the 35-kDa
bands are OspC and P35, respectively. The levels of expression of a
majority of the 10 proteins in the logrev sample were
between the levels found on days 4 and 6, as was expected from the
intermediate position of the logrev sampling point on the
growth curve. Apart from the changes noted for these 10 bands, there
were no significant changes in the intensities of the remaining bands
among the samples from days 3, 4, 6, 8, and logrev.
Examination by Western and Northern blotting of the expression of
several well-characterized antigens during in vitro growth of B. burgdorferi.
Next, we determined whether the expression of some of
the well-characterized borrelial antigens was affected by the growth phase of the spirochetes. Western blots were analyzed with monoclonal antibodies to BmpD, GroEL, flagellin, OspC, and P35 (Fig.
2), as well as to OspA, OspB, BmpA (P39),
and P72 (not shown). P35 was included as a control for a
growth-phase-regulated protein because in a previous study we had
demonstrated that its expression was upregulated during the
postexponential stages of growth (9).

View larger version (31K):
[in this window]
[in a new window]
|
FIG. 2.
Western blots showing the patterns of expression of
specific B. burgdorferi proteins during growth of the
spirochetes in vitro. The blots were developed with monoclonal or
monospecific polyclonal antibodies specific for the following proteins:
OspA, OspB, OspC, GroEL, P72, flagellin, BmpA, BmpD, and P35. Lanes 1 to 5 contain samples of the initial culture taken on days 3, 4, 6, and
8 and of the second subculture taken on day 5, respectively.
|
|
The Western blots did not reveal any significant changes in the levels
of OspA, OspB, BmpA, flagellin, and P72 during in vitro growth of
B. burgdorferi JD1, but they did reveal average increases of
four- and twofold in the levels of BmpD and GroEL, respectively, between the samples drawn on days 3 and 8 (Fig. 2; Table
2). In contrast, the level of OspC
increased up to 66-fold between the day 3 (logarithmic phase) and day 8 (postlogarithmic phase) time points (Fig. 2; Table 2), which was
consistent with the pattern observed for the 23-kDa protein in the
silver-stained gel and the Western blot developed with the infected
monkey serum. As expected, the expression of the control protein P35
was discernible only in the postlogarithmic and stationary phases (Fig.
2).
In order to correlate the protein expression with mRNA expression for
the above-described antigens of B. burgdorferi during growth
in culture, their steady-state mRNA profiles were visualized by
Northern blotting and probing with gene-specific sequences. Except with
bmpA and P35, where the probe hybridized to
multiple transcripts, in all other instances the gene-specific probes
detected a single transcript. The measured sizes of the transcripts for the examined genes were as follows: 1.8 kb for ospAB; 0.9 kb
for ospC; 2.4, 1.6, and 1.1 kb for bmpA; 1.3 kb
for bmpD; 1.75 kb for groEL; 1.35 kb for
fla; and 0.8, 1.0, and 1.2 kb for P35 (Fig. 3).

View larger version (94K):
[in this window]
[in a new window]
|
FIG. 3.
Northern blots showing the mRNA profiles for
ospAB, ospC, groEL, fla,
bmpAB, bmpD, and P35. It should be
noted that lanes 2 to 5 contain samples of the initial culture taken on
days 4, 6, and 8 of the second subculture taken on day 5, respectively.
|
|
The changes in the mRNA profiles of ospAB, fla,
groEL, and bmpA (all three detected transcripts)
were nearly indistinguishable from each other (Fig. 3). In each case,
there was a progressive decline in the level of mRNA between the level
found on day 4 and the level found on day 8 (Table
3). This finding is not surprising and is
in fact expected of most genes, given the gradual deceleration in the
various metabolic processes, including transcription, that occurs in
cells between the log and stationary phases. The bmpD mRNA
steady-state profile was overall similar to those of the above-described genes except that the level peaked on day 6 (Fig. 3;
Table 3), which can be best described, based on the growth curve in
Fig. 1A, as an early-stationary-phase time point. We also probed one
Northern blot with the P35 sequence to verify that the
results obtained were not a consequence of unequal levels of loading of
the RNA samples. The P35 probe hybridized to three transcripts of 0.8, 1.0, and 1.2 kb. This is not surprising because the
recent sequence analysis of the B. burgdorferi genome
revealed the presence of multiple homologs of this gene (7),
and therefore, the three transcripts may correspond to three different
P35 homologs. Nevertheless, there was a steady increase in
the cumulative level of the three transcripts as the spirochetes
progressed to the stationary phase. This was consistent with the steady
increase in the level of the P35 protein during the same time period
(Table 3).
 |
DISCUSSION |
In this paper we have extended our earlier study of the
phenomenon of the regulated expression of genes in B. burgdorferi during growth in vitro. We generally searched for
proteins that might be differentially expressed during in vitro growth
of these spirochetes and also specifically evaluated some of these
organisms' best-characterized antigens. We have so far identified 13 proteins whose expression levels are affected in cultured spirochetes
during growth from the logarithmic to the stationary phase. These
proteins include the previously described P35 and P7.5 (9)
and, from this study, P15, P16.5, P22, P23 (OspC), P27, P28, P29, P31,
and P43.5, based on an estimation of their apparent molecular weights as determined by SDS-PAGE. With the exception of P28, the expression of
the other seven newly identified proteins, including OspC, increased
steadily during growth from logarithmic to stationary phase, a pattern
of expression similar to that of P35 and P7.5. P28, on the other hand,
was expressed at a relatively higher level in the logarithmic phase
than in the stationary phase.
Among the previously characterized proteins individually tested with
specific monoclonal antibodies, OspC, GroEL, and BmpD displayed
differential levels of expression during growth of the spirochetes in
culture. The expression of OspA, OspB, BmpA, flagellin, and P72
remained largely constant throughout the culture period. There was an
excellent correlation between the mRNA and protein levels for
ospAB, bmpA, and fla. With
groEL, the marginal increase in the protein level during the
later stages of growth did not correspond to its mRNA levels at these
time points. Nevertheless, the overall good correlation between the
protein and the mRNA levels is strong evidence that the expression of
these genes, including groEL, is predominantly controlled at
the transcriptional level during in vitro growth of spirochetes in
BSK-H medium. Furthermore, the close resemblance of the steady-state
protein and RNA profiles of ospAB, bmpAB,
groEL, and fla may mean that these genes are regulated (or unregulated) similarly at the transcriptional level. However, this may not always be true of ospAB and
fla. ospAB expression has been found to be quite
varied at the RNA level among strains and between the different
passages of a given strain (10, 13). In addition, a
DNA-binding activity that binds to a region upstream of the
ospAB operon has been demonstrated recently in
stationary-phase spirochetes (14). Based on the 5' flanking
DNA sequence, it has been speculated that the expression of the
fla gene may be under the control of an alternative sigma
factor and hence may be regulated (17).
The expression of OspC increased steadily during the transition from
logarithmic to stationary phase. However, the expression of OspC in the
logrev sample was not always as expected. In one experiment, there was very little expression of OspC in the
logrev sample (data not shown), whereas its level of
expression in a repeat experiment was consistent with the pattern of a
steady increase with the increasing age of the culture (Fig. 1B and C). Several other studies have also demonstrated the variable expression of
OspC in cultured spirochetes (12, 15, 25, 28). More importantly, OspC has been shown to be upregulated by a shift in
culture temperature from 24 to 37°C (24) and this
induction occurs at the transcriptional level (27). It is
interesting to speculate, based on the results from this study, that
ospC expression may also be regulated transcriptionally and
translationally during growth in culture. First, the level of
ospC mRNA was relatively higher than those of
ospAB, bmpAB, groEL, and
fla throughout the culture period, suggesting that
ospC transcription may be active during both the logarithmic
and postlogarithmic phases, although the persistence of the
ospC mRNA may also reflect increased messenger stability.
Second, while the ospC mRNA level peaked on day 4 (late logarithmic phase) the protein level reached a maximum only on day 6 (early stationary phase) (Fig. 1B and 2). By contrast, as mentioned
above, the levels of expression of other proteins, such as OspA, OspB,
flagellin, BmpA, and GroEL, correlated very well with their levels of
mRNA. This result hints at the possibility of additional translational
control of ospC expression.
The expression of bmpD also appears to be regulated in
vitro, but the pattern of RNA expression suggests an entirely different mechanism from that of ospC or P35 RNA
expression. The levels of bmpD mRNA and protein peaked at
the onset of the stationary phase, unlike those of the genes that are
expressed early in logarithmic phase and of the 11 antigens, including
P7.5, P35, and ospC, whose expression
continued to increase late in growth. The notion of regulated
expression of bmpD is supported by the presence of a 13-bp
inverted repeat sequence upstream of the gene and overlapping the
putative
35 region (21). Furthermore, this overlap of the inverted repeat with the
35 region and the lack of a consensus
35
sequence suggest that bmpD may be positively regulated,
being turned on or induced by the binding of a transcriptional
activator to the inverted-repeat region.
Interestingly, in all our Western blots developed either with
infected-monkey serum or with specific monoclonal antibodies we saw no
evidence for a decrease in the levels of antigens during the culture
period. In other words, once these antigens were synthesized, their
levels were maintained by the bacterial cell throughout the culture
period. Included in this group of antigens are some of the
well-characterized lipoproteins of B. burgdorferi such as
OspA, OspB, OspC, BmpA, and BmpD and the nonlipidated flagellin. Therefore, the diminished expression of proteins such as OspA and OspB
that has been observed in tick-borne spirochetes after a tick blood
meal (23) may reflect a combination of transcriptional repression of the OspAB operon and selective loss of these proteins during rapid spirochetal multiplication.
The 18 proteins, including OspC, that are recognized by the serum of
the B. burgdorferi-infected rhesus monkey correspond to
antigens that are present in the spirochete during the early stages of
infection. However, OspC expression is known to be turned on in the
spirochetes within the tick gut during the course of a blood meal and
to continue following infection of the mammalian host. It is tempting
then to speculate that the other nine antigens that are upregulated
like OspC during growth from logarithmic to stationary phase in vitro
may also be similarly turned on within the tick during the course of
the blood meal prior to invasion of the mammalian host. Surprisingly,
the same serum failed to bind to the abundantly expressed and
logarithmic-phase-specific protein P28. This may simply mean that P28
is not immunogenic or that it is absent in spirochetes during the early
stages of invasion of the mammalian host.
To summarize, in our earlier paper we suggested that the lipoprotein
P35, whose expression is transcriptionally regulated in vitro, might be
used as a model to dissect mechanisms of gene expression in B. burgdorferi. We have now identified other proteins, including
BmpD, OspC, and P28, all of which also may be used for this purpose.
 |
ACKNOWLEDGMENTS |
This work was supported by grants AI 35027 and RR00164 from the
National Institutes of Health.
We thank Laura Povinelli for help with the production of mouse
anti-BmpD antiserum and Barbara J. B. Johnson (Centers for Disease
Control and Prevention, Fort Collins, Colo.) and Bettina Wilske (Max
von Pettenkofer Institut) for kindly providing monoclonal antibodies.
The excellent secretarial help of Christie Trew and the photographic
skill of Murphy Dowouis are acknowledged with thanks.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: TRPRC, 18703 Three Rivers Rd., Covington, LA 70433. Phone: (504) 892-2040, ext. 221. Fax: (504) 893-1352. E-mail: philipp{at}tpc.tulane.edu.
Editor:
J. G. Cannon
 |
REFERENCES |
| 1.
|
Aydintug, M.,
Y. Gu, and M. T. Philipp.
1994.
Borrelia burgdorferi antigens that are targeted by antibody-dependent, complement-mediated killing in the rhesus monkey.
Infect. Immun.
62:4929-4937[Abstract/Free Full Text].
|
| 2.
|
Bledsoe, H. A.,
J. A. Carrol,
T. R. Whelchel,
M. A. Farmer,
D. W. Dorward, and F. C. Gherardini.
1994.
Isolation and partial characterization of Borrelia burgdorferi inner and outer membranes by using isopycnic centrifugation.
J. Bacteriol.
176:7447-7455[Abstract/Free Full Text].
|
| 3.
|
Das, S.,
S. W. Barthold,
S. S. Giles,
R. R. Montgomery,
S. R. Telford III, and E. Fikrig.
1997.
Temporal pattern of Borrelia burgdorferi p21 expression in ticks and the mammalian host.
J. Clin. Investig.
99:987-995[Medline].
|
| 4.
|
de Silva, A. M., and E. Fikrig.
1995.
Growth and migration of Borrelia burgdorferi in Ixodes ticks during blood feeding.
Am. J. Trop. Med. Hyg.
53:397-404.
|
| 5.
|
de Silva, A. M.,
S. R. Telford III,
L. R. Brunet,
S. W. Barthold, and E. Fikrig.
1996.
Borrelia burgdorferi is an arthropod-specific transmission-blocking Lyme disease vaccine.
J. Exp. Med.
183:271-275[Abstract/Free Full Text].
|
| 6.
|
Fingerle, V.,
U. Hauser,
G. Liegl,
B. Petko,
V. Preac-Mursic, and B. Wilske.
1995.
Expression of outer surface proteins A and C of Borrelia burgdorferi in Ixodes ricinus.
J. Clin. Microbiol.
33:1867-1869[Abstract].
|
| 7.
|
Fraser, C. M.,
S. Casjens,
W. M. Huang,
G. G. Sutton,
R. Clayton,
R. Lathigra,
O. White,
K. A. Ketchum,
R. Dodson,
E. K. Hickey,
M. Gwinn,
B. Dougherty,
J.-F. Tomb,
R. D. Fleischmann,
D. Richardson,
J. Peterson,
A. R. Kerlavage,
J. Quackenbush,
S. Salzberg,
M. Hanson,
R. van Vugt,
N. Palmer,
M. D. Adams,
J. Gocayne,
J. Weidman,
T. Utterback,
L. Whattey,
L. McDonald,
P. Artiach,
C. Bowman,
S. Garland,
C. Fujii,
M. D. Cotton,
K. Horst,
K. Roberts,
B. Hatch,
H. O. Smith, and J. C. Venter.
1997.
Genome sequence of a Lyme disease spirochaete, Borrelia burgdorferi.
Nature
390:580-586[Medline].
|
| 8.
|
Gilmore, R. D., Jr.,
K. J. Kappel, and B. J. Johnson.
1997.
Molecular characterization of a 35-kilodalton protein of Borrelia burgdorferi, an antigen of diagnostic importance in early Lyme disease.
J. Clin. Microbiol.
35:86-91[Abstract].
|
| 9.
|
Indest, K. J.,
R. Ramamoorthy,
M. Solé,
R. D. Gilmore,
B. J. B. Johnson, and M. T. Philipp.
1997.
Cell-density-dependent expression of Borrelia burgdorferi lipoproteins in vitro.
Infect. Immun.
65:1165-1171[Abstract].
|
| 10.
|
Jonsson, M., and S. Bergstrom.
1995.
Transcriptional and translational regulation of the expression of the major outer surface proteins in Lyme disease Borrelia strains.
Microbiology
141:1321-1329[Abstract].
|
| 11.
|
Lahdenne, P.,
S. F. Porcella,
K. E. Hagman,
D. R. Akins,
T. G. Popova,
D. L. Cox,
L. I. Katona,
J. D. Radolf, and M. V. Norgard.
1997.
Molecular characterization of a 6.6-kilodalton Borrelia burgdorferi outer membrane-associated lipoprotein (lp6.6) which appears to be downregulated during mammalian infection.
Infect. Immun.
65:412-421[Abstract].
|
| 12.
|
Marconi, R. T.,
D. S. Samuels, and C. F. Garon.
1993.
Transcriptional analyses and mapping of the ospC gene in Lyme disease spirochetes.
J. Bacteriol.
175:926-932[Abstract/Free Full Text].
|
| 13.
|
Margolis, N., and P. A. Rosa.
1993.
Regulation of expression of major outer surface proteins in Borrelia burgdorferi.
Infect. Immun.
61:2207-2210[Abstract/Free Full Text].
|
| 14.
|
Margolis, N., and D. S. Samuels.
1995.
Proteins binding to the promoter region of the operon encoding the major outer surface proteins OspA and OspB of Borrelia burgdorferi.
Mol. Biol. Rep.
21:159-164[Medline].
|
| 15.
|
Masuzawa, T.,
T. Kurita,
H. Kawabata, and Y. Yanagihara.
1994.
Relationship between infectivity and OspC expression in Lyme disease Borrelia.
FEMS Microbiol. Lett.
123:319-324[Medline].
|
| 16.
|
Mather, T. N.,
M. L. Wilson,
S. I. Moore,
J. M. C. Ribeiro, and A. Spielman.
1989.
Comparing the relative potential of rodents as reservoirs of the Lyme disease spirochete.
Am. J. Epidemiol.
130:143-150[Abstract/Free Full Text].
|
| 17.
|
Noppa, L.,
N. Burman,
A. Sadziene,
A. G. Barbour, and S. Bergstrom.
1995.
Expression of the flagellin gene in Borrelia is controlled by an alternative sigma factor.
Microbiology
141:85-93[Abstract].
|
| 18.
|
Piesman, J.,
T. N. Mather,
R. Sinsky, and A. Spielman.
1987.
Duration of tick attachment and Borrelia burgdorferi transmission.
J. Clin. Microbiol.
25:557-558[Abstract/Free Full Text].
|
| 19.
|
Piesman, J.,
J. R. Oliver, and R. J. Sinsky.
1990.
Growth kinetics of the Lyme disease spirochete (Borrelia burgdorferi) in vector ticks (Ixodes dammini).
Am. J. Trop. Med. Hyg.
42:352-357.
|
| 20.
|
Pollack, R. J.,
S. R. Telford III, and A. Spielman.
1993.
Standardization of medium for culturing Lyme disease spirochetes.
J. Clin. Microbiol.
31:1251-1255[Abstract/Free Full Text].
|
| 21.
|
Ramamoorthy, R.,
L. Povinelli, and M. T. Philipp.
1996.
Molecular characterization, genomic arrangement, and expression of bmpD, a new member of the bmp class of genes encoding membrane proteins of Borrelia burgdorferi.
Infect. Immun.
64:1259-1264[Abstract].
|
| 22.
|
Roberts, E. D.,
R. P. Bohm, Jr.,
F. B. Cogswell,
H. N. Lanners,
R. C. Lowrie, Jr.,
L. Povinelli,
J. Piesman, and M. T. Philipp.
1995.
Chronic Lyme disease in the rhesus monkey.
Lab. Investig.
72:146-160[Medline].
|
| 23.
|
Schwan, T. G.,
J. Piesman,
W. T. Golde,
M. C. Dolan, and P. A. Rosa.
1995.
Induction of an outer surface protein on Borrelia burgdorferi during tick feeding.
Proc. Natl. Acad. Sci. USA
92:2909-2913[Abstract/Free Full Text].
|
| 24.
|
Stevenson, B.,
T. G. Schwan, and P. A. Rosa.
1995.
Temperature-related differential expression of antigens in the Lyme disease spirochete, Borrelia burgdorferi.
Infect. Immun.
63:4535-4539[Abstract].
|
| 25.
|
Stevenson, B., and S. W. Barthold.
1994.
Expression and sequence of outer surface protein C among North American isolates of Borrelia burgdorferi.
FEMS Microbiol. Lett.
124:367-372[Medline].
|
| 26.
|
Suk, K.,
S. Das,
W. Sun,
B. Jwang,
S. W. Barthold,
R. A. Flavell, and E. Fikrig.
1995.
Borrelia burgdorferi genes selectively expressed in the infected host.
Proc. Natl. Acad. Sci. USA
92:4269-4273[Abstract/Free Full Text].
|
| 27.
|
Tilly, K.,
S. Casjens,
B. Stevenson,
J. L. Bono,
D. S. Samuels,
D. Hogan, and P. Rosa.
1997.
The Borrelia burgdorferi circular plasmid cp26: conservation of plasmid structure and targeted inactivation of the ospC gene.
Mol. Microbiol.
25:361-373[Medline].
|
| 28.
|
Wilske, B.,
V. Preac-Mursic,
S. Jauris,
A. Hofmann,
I. Pradel,
E. Soutschek,
E. Schwab,
G. Will, and G. Wanner.
1993.
Immunological and molecular polymorphisms of OspC, an immunodominant major surface protein of Borrelia burgdorferi.
Infect. Immun.
61:2182-2191[Abstract/Free Full Text].
|
Infection and Immunity, November 1998, p. 5119-5124, Vol. 66, No. 11
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Embers, M. E., Alvarez, X., Ooms, T., Philipp, M. T.
(2008). The Failure of Immune Response Evasion by Linear Plasmid 28-1-Deficient Borrelia burgdorferi Is Attributable to Persistent Expression of an Outer Surface Protein. Infect. Immun.
76: 3984-3991
[Abstract]
[Full Text]
-
Gautam, A., Hathaway, M., McClain, N., Ramesh, G., Ramamoorthy, R.
(2008). Analysis of the determinants of bba64 (P35) gene expression in Borrelia burgdorferi using a gfp reporter. Microbiology
154: 275-285
[Abstract]
[Full Text]
-
Blevins, J. S., Revel, A. T., Smith, A. H., Bachlani, G. N., Norgard, M. V.
(2007). Adaptation of a Luciferase Gene Reporter and lac Expression System to Borrelia burgdorferi. Appl. Environ. Microbiol.
73: 1501-1513
[Abstract]
[Full Text]
-
Caimano, M. J., Eggers, C. H., Gonzalez, C. A., Radolf, J. D.
(2005). Alternate Sigma Factor RpoS Is Required for the In Vivo-Specific Repression of Borrelia burgdorferi Plasmid lp54-Borne ospA and lp6.6 Genes. J. Bacteriol.
187: 7845-7852
[Abstract]
[Full Text]
-
Ramamoorthy, R., McClain, N. A., Gautam, A., Scholl-Meeker, D.
(2005). Expression of the bmpB Gene of Borrelia burgdorferi Is Modulated by Two Distinct Transcription Termination Events. J. Bacteriol.
187: 2592-2600
[Abstract]
[Full Text]
-
Cluss, R. G., Silverman, D. A., Stafford, T. R.
(2004). Extracellular Secretion of the Borrelia burgdorferi Oms28 Porin and Bgp, a Glycosaminoglycan Binding Protein. Infect. Immun.
72: 6279-6286
[Abstract]
[Full Text]
-
Tokarz, R., Anderton, J. M., Katona, L. I., Benach, J. L.
(2004). Combined Effects of Blood and Temperature Shift on Borrelia burgdorferi Gene Expression as Determined by Whole Genome DNA Array. Infect. Immun.
72: 5419-5432
[Abstract]
[Full Text]
-
Blevins, J. S., Revel, A. T., Caimano, M. J., Yang, X. F., Richardson, J. A., Hagman, K. E., Norgard, M. V.
(2004). The luxS Gene Is Not Required for Borrelia burgdorferi Tick Colonization, Transmission to a Mammalian Host, or Induction of Disease. Infect. Immun.
72: 4864-4867
[Abstract]
[Full Text]
-
Yang, X. F., Hubner, A., Popova, T. G., Hagman, K. E., Norgard, M. V.
(2003). Regulation of Expression of the Paralogous Mlp Family in Borrelia burgdorferi. Infect. Immun.
71: 5012-5020
[Abstract]
[Full Text]
-
Hodzic, E., Feng, S., Freet, K. J., Barthold, S. W.
(2003). Borrelia burgdorferi Population Dynamics and Prototype Gene Expression during Infection of Immunocompetent and Immunodeficient Mice. Infect. Immun.
71: 5042-5055
[Abstract]
[Full Text]
-
Carroll, J. A., Stewart, P. E., Rosa, P., Elias, A. F., Garon, C. F.
(2003). An enhanced GFP reporter system to monitor gene expression in Borrelia burgdorferi. Microbiology
149: 1819-1828
[Abstract]
[Full Text]
-
Hubner, A., Revel, A. T., Nolen, D. M., Hagman, K. E., Norgard, M. V.
(2003). Expression of a luxS Gene Is Not Required for Borrelia burgdorferi Infection of Mice via Needle Inoculation. Infect. Immun.
71: 2892-2896
[Abstract]
[Full Text]
-
Ojaimi, C., Brooks, C., Casjens, S., Rosa, P., Elias, A., Barbour, A., Jasinskas, A., Benach, J., Katona, L., Radolf, J., Caimano, M., Skare, J., Swingle, K., Akins, D., Schwartz, I.
(2003). Profiling of Temperature-Induced Changes in Borrelia burgdorferi Gene Expression by Using Whole Genome Arrays. Infect. Immun.
71: 1689-1705
[Abstract]
[Full Text]
-
Stevenson, B., Babb, K.
(2002). LuxS-Mediated Quorum Sensing in Borrelia burgdorferi, the Lyme Disease Spirochete. Infect. Immun.
70: 4099-4105
[Abstract]
[Full Text]
-
Hodzic, E., Feng, S., Freet, K. J., Borjesson, D. L., Barthold, S. W.
(2002). Borrelia burgdorferi Population Kinetics and Selected Gene Expression at the Host-Vector Interface. Infect. Immun.
70: 3382-3388
[Abstract]
[Full Text]
-
Lin, T., Oliver, J. H. Jr., Gao, L.
(2002). Genetic Diversity of the Outer Surface Protein C Gene of Southern Borrelia Isolates and Its Possible Epidemiological, Clinical, and Pathogenetic Implications. J. Clin. Microbiol.
40: 2572-2583
[Abstract]
[Full Text]
-
Indest, K. J., Howell, J. K., Jacobs, M. B., Scholl-Meeker, D., Norris, S. J., Philipp, M. T.
(2001). Analysis of Borrelia burgdorferivlsE Gene Expression and Recombination in the Tick Vector. Infect. Immun.
69: 7083-7090
[Abstract]
[Full Text]
-
Hubner, A., Yang, X., Nolen, D. M., Popova, T. G., Cabello, F. C., Norgard, M. V.
(2001). Expression of Borrelia burgdorferi OspC and DbpA is controlled by a RpoN-RpoS regulatory pathway. Proc. Natl. Acad. Sci. USA
98: 12724-12729
[Abstract]
[Full Text]
-
Carroll, J. A., El-Hage, N., Miller, J. C., Babb, K., Stevenson, B.
(2001). Borrelia burgdorferi RevA Antigen Is a Surface-Exposed Outer Membrane Protein Whose Expression Is Regulated in Response to Environmental Temperature and pH. Infect. Immun.
69: 5286-5293
[Abstract]
[Full Text]
-
Rathinavelu, S., de Silva, A. M.
(2001). Purification and Characterization of Borrelia burgdorferi from Feeding Nymphal Ticks (Ixodes scapularis). Infect. Immun.
69: 3536-3541
[Abstract]
[Full Text]
-
Babb, K., El-Hage, N., Miller, J. C., Carroll, J. A., Stevenson, B.
(2001). Distinct Regulatory Pathways Control Expression of Borrelia burgdorferi Infection-Associated OspC and Erp Surface Proteins. Infect. Immun.
69: 4146-4153
[Abstract]
[Full Text]
-
Yang, X., Popova, T. G., Goldberg, M. S., Norgard, M. V.
(2001). Influence of Cultivation Media on Genetic Regulatory Patterns in Borrelia burgdorferi. Infect. Immun.
69: 4159-4163
[Abstract]
[Full Text]
-
Ramamoorthy, R., Scholl-Meeker, D.
(2001). Borrelia burgdorferi Proteins Whose Expression Is Similarly Affected by Culture Temperature and pH. Infect. Immun.
69: 2739-2742
[Abstract]
[Full Text]
-
Labandeira-Rey, M., Baker, E. A., Skare, J. T.
(2001). VraA (BBI16) Protein of Borrelia burgdorferi Is a Surface-Exposed Antigen with a Repetitive Motif That Confers Partial Protection against Experimental Lyme Borreliosis. Infect. Immun.
69: 1409-1419
[Abstract]
[Full Text]
-
Purser, J. E., Norris, S. J.
(2000). Correlation between plasmid content and infectivity in Borrelia burgdorferi. Proc. Natl. Acad. Sci. USA
97: 13865-13870
[Abstract]
[Full Text]
-
Carroll, J. A., Cordova, R. M., Garon, C. F.
(2000). Identification of 11 pH-Regulated Genes in Borrelia burgdorferi Localizing to Linear Plasmids. Infect. Immun.
68: 6677-6684
[Abstract]
[Full Text]
-
Elias, A. F., Bono, J. L., Carroll, J. A., Stewart, P., Tilly, K., Rosa, P.
(2000). Altered Stationary-Phase Response in a Borrelia burgdorferi rpoS Mutant. J. Bacteriol.
182: 2909-2918
[Abstract]
[Full Text]
-
Anguita, J., Samanta, S., Revilla, B., Suk, K., Das, S., Barthold, S. W., Fikrig, E.
(2000). Borrelia burgdorferi Gene Expression In Vivo and Spirochete Pathogenicity. Infect. Immun.
68: 1222-1230
[Abstract]
[Full Text]
-
Indest, K. J., Philipp, M. T.
(2000). DNA-Binding Proteins Possibly Involved in Regulation of the Post-Logarithmic-Phase Expression of Lipoprotein P35 in Borrelia burgdorferi. J. Bacteriol.
182: 522-525
[Abstract]
[Full Text]
-
Schwan, T. G., Piesman, J.
(2000). Temporal Changes in Outer Surface Proteins A and C of the Lyme Disease-Associated Spirochete, Borrelia burgdorferi, during the Chain of Infection in Ticks and Mice. J. Clin. Microbiol.
38: 382-388
[Abstract]
[Full Text]
-
Liang, F. T., Steere, A. C., Marques, A. R., Johnson, B. J. B., Miller, J. N., Philipp, M. T.
(1999). Sensitive and Specific Serodiagnosis of Lyme Disease by Enzyme-Linked Immunosorbent Assay with a Peptide Based on an Immunodominant Conserved Region of Borrelia burgdorferi VlsE. J. Clin. Microbiol.
37: 3990-3996
[Abstract]
[Full Text]
-
Yang, X., Popova, T. G., Hagman, K. E., Wikel, S. K., Schoeler, G. B., Caimano, M. J., Radolf, J. D., Norgard, M. V.
(1999). Identification, Characterization, and Expression of Three New Members of the Borrelia burgdorferi Mlp (2.9) Lipoprotein Gene Family. Infect. Immun.
67: 6008-6018
[Abstract]
[Full Text]
-
Hellwage, J., Meri, T., Heikkila, T., Alitalo, A., Panelius, J., Lahdenne, P., Seppala, I. J. T., Meri, S.
(2001). The Complement Regulator Factor H Binds to the Surface Protein OspE of Borrelia burgdorferi. J. Biol. Chem.
276: 8427-8435
[Abstract]
[Full Text]